JOHNSON & JOHNSON

Trading Ideas Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 21:00:02 08/05/2024 BST			5-day change	1st Jan Change
149 ^USD	+0.15%		+3.02%	-4.97%

05-07	Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobs	RE
05-06	J&J: encouraging results in prostate cancer	CF

Trading Ideas

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JOHNSON & JOHNSON :An end to the technical rebound lies ahead	27/11/19
JOHNSON & JOHNSON :The underlying trend is to the upside	12/06/17
JOHNSON & JOHNSON :Expect the comeback of a strong trend	10/05/17
JOHNSON & JOHNSON :Buying pressure	22/12/16
JOHNSON & JOHNSON :A good level to buy	12/09/16
JOHNSON & JOHNSON :Towards historic highs	26/09/12
JOHNSON & JOHNSON :Beginning of a bearish movement	26/06/12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 05:30 pm

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer